<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02323503</url>
  </required_header>
  <id_info>
    <org_study_id>CR018</org_study_id>
    <nct_id>NCT02323503</nct_id>
  </id_info>
  <brief_title>Assessment of Ventricular Arrhythmia Risk After CRT-D Replacement for Patients With Primary Prevention Indication</brief_title>
  <acronym>BioCONTINUE</acronym>
  <official_title>BIOtronik Study to Assess the CONTINUation of Existing Risk of Ventricular Arrhythmias After CRT-D Replacement for Patients With Primary Prevention Indication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac resynchronization therapy (CRT) has been shown to reduce heart failure (HF),
      hospitalizations and death in patients with left ventricular ejection fraction (LVEF) &lt;35%
      and wide QRS. CRT provides electromechanical resynchronization and improves LV systolic
      function. The induced LV reverse remodeling or near normalization in LVEF to ≥45% is
      associated with a significant reduction in the risk of subsequent life-threatening
      ventricular tachyarrhythmias (VTA). And at the time of replacement, the need for
      defibrillator back-up after an event-free first CRT-D service-life for patients with improved
      LVEF is a controversy question.

      80% of Implantable Cardioverter Defibrillator (ICD) patients implanted for primary prevention
      do not experience VTA during the life-time of their first device.

      So, regarding patients implanted with a CRT-D for primary prevention at the time of first
      implantation, the question is will they experience VTA after their device replacement by
      another CRT-D.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to describe, in a population of patients who had a primary
      prevention ICD indication at first implantation of a CRT-D, the relevance defibrillator
      back-up after the replacement of the first CRT-D. For that, the rate of patients with at
      least one sustained VTA detected by the CRT-D or a conventional surface ECG will be assessed
      after the device replacement.

      Furthermore, the association between the baseline characteristics of the CRT-D population
      after replacement and the risk of subsequent VTA will be explored after a minimum of two
      years FU.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Assess the rate of patients with at least one sustained VTA after replacement</measure>
    <time_frame>up to two years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with at least one VTA for 4 specific subgroups</measure>
    <time_frame>After the device replacement and after a minimum of two years follow-up (FU)</time_frame>
    <description>Grp R[1-4]: LVEF ≥40% / &lt;40% at the time of replacement and with / without previous VTA during the lifetime of their first CRT-D device</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Rate of patients with ventricular tachycardia or ventricular fibrillation events, with appropriate therapies</measure>
    <time_frame>After the device replacement and after a minimum of two years FU</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Rate of patients with inappropriate therapies/diagnosis</measure>
    <time_frame>After the device replacement and after a minimum of two years FU</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline factor predictors of ventricular events</measure>
    <time_frame>After the device replacement and after a minimum of two years FU</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Serious adverse events related to ventricular events / inappropriate therapies</measure>
    <time_frame>After the device replacement and after a minimum of two years FU</time_frame>
  </other_outcome>
  <enrollment type="Actual">289</enrollment>
  <condition>Cardiac Resynchronization</condition>
  <condition>Biventricular Pacemakers, Artificial</condition>
  <condition>Cardioverter-Defibrillators, Implantable</condition>
  <condition>Device Replacement</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CRT-D device replacement</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients initially implanted with a CRT-D (cardiac resynchronization therapy with
        defibrillator) device for primary prevention indication for defibrillation, requiring a
        device replacement by another CRT-D because of battery depletion
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with primary prevention indication for defibrillation at the time of the first
             CRT-D implantation

          -  Patient implanted as first replacement by a CRT-D device (CRT-D by CRT-D)

          -  Lifetime of the previous CRT-D &gt; 3 years

          -  Patient willing and able to comply with the protocol and who has provided written
             informed consent

          -  Patient whose medical situation is stable.

        Exclusion Criteria:

          -  Patient with an ICD lead under advisory (e.g. Fidelis lead)

          -  Right or left ventricular leads exchange during CRT-D replacement

          -  Non functional atrial or right/left ventricular leads

          -  Life expectancy &lt; 1 year

          -  Age &lt; 18 years

          -  Pregnant woman or woman who plan to become pregnant during the trial

          -  Participation in another interventional clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel DG Gras, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nouvelles Cliniques Nantaises, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>OLV Aalst</name>
      <address>
        <city>Aalst</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH d'Annecy</name>
      <address>
        <city>Annecy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Cavale Blanche</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Caen</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Du Bocage</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Limoges</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Saint Philibert</name>
      <address>
        <city>Lomme</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cliniques du Tonkin, de la Sauvegarde et Protestante</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Clairval</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Mercy</name>
      <address>
        <city>Metz</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Nancy</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nouvelles Cliniques Nantaises</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de la Pitié Salpétrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Pessac</name>
      <address>
        <city>Pessac</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Hôpital CHarles Nicolle</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Saint-Etienne</name>
      <address>
        <city>Saint-Etienne</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31403</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Tours</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schuechtermann-Klinik</name>
      <address>
        <city>Bad Rothenfelde</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stadtisches Klinikum Brandenburg</name>
      <address>
        <city>Brandenburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DRK-Krankenhaus Moelln Ratzeburg</name>
      <address>
        <city>Ratzeburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiological Praxis</name>
      <address>
        <city>Rostock</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Semmelweis University</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barzilai Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Versilia</name>
      <address>
        <city>Lido di Camaiore</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Mediterranea</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Chiara</name>
      <address>
        <city>Pisa</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Santa Maria</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Santa Marta</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Burgos</name>
      <address>
        <city>Burgos</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marques de Valdecilla</name>
      <address>
        <city>Santander</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Portugal</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2014</study_first_submitted>
  <study_first_submitted_qc>December 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2014</study_first_posted>
  <last_update_submitted>October 26, 2017</last_update_submitted>
  <last_update_submitted_qc>October 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CRT-D</keyword>
  <keyword>replacement</keyword>
  <keyword>primary prevention</keyword>
  <keyword>ventricular tachyarrhythmias</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

